Cargando…

The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis

Polycystic ovary syndrome (PCOS) is the most common endocrinopathies affecting the early reproductive age in women, whose pathophysiology perplexes many researchers till today. This syndrome is classically categorized by hyperandrogenism and/or hyperandrogenemia, menstrual and ovulatory dysfunction,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaudhary, Hiral, Patel, Jalpa, Jain, Nayan K., Joshi, Rushikesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466925/ https://www.ncbi.nlm.nih.gov/pubmed/34563259 http://dx.doi.org/10.1186/s13048-021-00879-w

Ejemplares similares

Association of FTO gene variant rs9939609 with polycystic ovary syndrome from Gujarat, India
por: Chaudhary, Hiral, et al.
Publicado: (2023)

Assessment of gut microbial β-glucuronidase and β-glucosidase activity in women with polycystic ovary syndrome
por: Patel, Jalpa, et al.
Publicado: (2023)

Vitamin D receptor gene polymorphism and polycystic ovary syndrome susceptibility
por: Albahlol, Ibrahim A, et al.
Publicado: (2023)

Potential genetic polymorphisms predicting polycystic ovary syndrome
por: Chen, Yao, et al.
Publicado: (2018)

The role of cholecalciferol deficiency in the pathogenesis of polycystic ovary syndrome
por: Safi, Aigul, et al.
Publicado: (2020)

Polymorphisms in FSHR modulating susceptibility to polycystic ovary syndrome: an updated meta-analysis
por: Kaur, Mandeep, et al.
Publicado: (2023)

The Role of the Brain in the Pathogenesis and Physiology of Polycystic Ovary Syndrome (PCOS)
por: Coutinho, Eulalia A., et al.
Publicado: (2019)

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
por: Dewailly, Didier, et al.
Publicado: (2020)

Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment
por: Zhao, Han, et al.
Publicado: (2023)

Depression in polycystic ovary syndrome: Focusing on pathogenesis and treatment
por: Xing, Liwei, et al.
Publicado: (2022)

MTHFR C677T polymorphism is associated with hyperlipidemia in women with polycystic ovary syndrome
por: Jain, Madhu, et al.
Publicado: (2012)

Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India
por: Ganie, Mohammad Ashraf, et al.
Publicado: (2019)

Relationships of ferroptosis-related genes with the pathogenesis in polycystic ovary syndrome
por: Lin, Shuang, et al.
Publicado: (2023)

A narrative review of the role of gastrointestinal dysbiosis in the pathogenesis of polycystic ovary syndrome
por: Parker, Jim, et al.
Publicado: (2022)

Clinical outcome of various metformin treatments for women with polycystic ovary syndrome
por: Matsuzaki, Toshiya, et al.
Publicado: (2017)

RS1799817 in INSR associates with susceptibility to polycystic ovary syndrome
por: Daghestani, Maha H.
Publicado: (2020)

Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
por: Barber, Thomas M, et al.
Publicado: (2019)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Statistical Genomic Approach Identifies Association between FSHR Polymorphisms and Polycystic Ovary Morphology in Women with Polycystic Ovary Syndrome
por: Du, Tao, et al.
Publicado: (2015)

Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women
por: Ashraf, Sairish, et al.
Publicado: (2021)

Family-based analysis of eight susceptibility loci in polycystic ovary syndrome
por: Zhao, Shigang, et al.
Publicado: (2015)

Relationship between the characteristic traits of polycystic ovary syndrome and susceptibility genes
por: Hong, So-hyeon, et al.
Publicado: (2020)

Polycystic Ovary Syndrome Susceptibility Loci Inform Disease Etiological Heterogeneity
por: Zhang, Yanfei, et al.
Publicado: (2021)

The role of the thyroid in polycystic ovary syndrome
por: Fan, Huanhuan, et al.
Publicado: (2023)

Involvement of Transcription Factor FoxO1 in the Pathogenesis of Polycystic Ovary Syndrome
por: Xu, Renfeng, et al.
Publicado: (2021)

Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
por: Sadeghi, Hosna Mohammad, et al.
Publicado: (2022)

Long non-coding RNAs: novel players in the pathogenesis of polycystic ovary syndrome
por: Tu, Mixue, et al.
Publicado: (2021)

SUN-012 Role of Leptin-Receptor Expressing Cells in the Pathogenesis of Polycystic Ovary Syndrome (PCOS)
por: Cara, Alexandra, et al.
Publicado: (2020)

The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
por: Anala, Alekya Devi, et al.
Publicado: (2023)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Polycystic Ovary Syndrome in Adolescence
por: Deans, Rebecca
Publicado: (2019)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

Quercetin and polycystic ovary syndrome
por: Ma, Congshun, et al.
Publicado: (2022)

Polycystic Ovary Syndrome and COVID-19: An Emerging Risk Factor
por: Joshi, Shashank R.
Publicado: (2021)

Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19
por: Ilias, Ioannis, et al.
Publicado: (2021)

Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
por: Layacha, Sakshi Y, et al.
Publicado: (2023)

IL-15 Participates in the Pathogenesis of Polycystic Ovary Syndrome by Affecting the Activity of Granulosa Cells
por: Liu, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0ep8g93nremtpi1781l111426r